After several years of growing popularity, use of IVC filters started falling in 2010 – shortly after the FDA issued a safety alert about the long-term use of these devices. According to two studies presented at a recent meeting of the Society of Interventional Radiology, this decrease can be attributed to the FDA warning.
Retinopathy of Prematurity, or ROP, is a condition affecting premature infants. This happens when abnormal blood vessels start growing and spreading across the retina, which can cause retinal detachment, resulting in permanent blindness.
It is one of the leading causes of vision impairment in children, and the consequences can last a lifetime. The good news is that recent research and advances in the diagnosis and treatment of ROP means better outcomes for children who are affected by this disorder.
This week, the Allegheny County Council voted to ban e-cigarette use in public spaces, being the second county in Pennsylvania to do so. The practice of “vaping” is no longer permitted in offices and other indoor workplaces, schools, indoor sports and entertainment venues, health care facilities and bus and train stations.
The Essure contraceptive device is associated with numerous complications. These include severe cramps, painful intercourse, sudden and unexplained weight gain, and excessive bleeding, along with allergic reactions caused by the nickel titanium alloy used in the manufacturing process.
Last month, corporate poisoners DuPont and Chemours announced their agreement to settle approximately 3,500 lawsuits filed by Ohio River Valley residents over injuries and deaths due to C-8, also known as perfluorooctanoic acid (PFOA for short).
Last October, the FDA was prepared to remove two generic versions of the ADHD drug Concerta (methylphenidate hydrochloride) from the market, citing the medication failed to perform adequately. Now, the federal regulatory agency is giving drugmakers Lannett and Mallinckrodt Pharmaceuticals an additional month to demonstrate why it should be allowed to remain.
Warfarin (a form of rat poison still sold as Coumadin) has been the standard anticoagulant for going on six decades. It is far from a perfect treatment: determining the correct dosage can be difficult, and patients must go on a restricted diet and undergo constant monitoring because of numerous interactions (frequently an issue with elderly patients on numerous prescriptions).
Over the past two months, the number of lawsuits against Taxotere maker Sanofi-Aventis has nearly tripled, going from 260 to more than 700. This comes in the wake of the consolidation of all federal lawsuits into multi-district litigation (MDL) before the Honorable Judge Kurt D. Engelhart in U.S. District Court for the Eastern District of Louisiana last fall.